Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
8 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN - 2Remote Headphones: Upgrade Your Sound Insight
- 3Bavarian leader questions Germany's Eurovision participation
- 4Step by step instructions to Deal with Your Time While Chasing after an Internet based Degree
- 5Greenland’s melting ice and landslide-prone fjords make the oil and minerals Trump is eyeing dangerous to extract
- Home Plan Tips for Seniors
- Incredible Travel Objections for Craftsmanship Darlings to Visit
- The Developing Nearby Food Development and Its Advantages
- A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
- Poland open to German troops to help secure Ukraine ceasefire
- Family-Accommodating Snow Sports Experiences
- New movies to watch this weekend: See 'We Bury the Dead' in theaters, rent 'Wicked: For Good,' stream 'The Unbreakable Boy' on Starz
- Watch This Glacier Race into the Sea
- Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
